1 |
Mcrae J, Sugar RM, Shipley B, Hook GR. Alterations in tissue distribution of Tc-99m pertechnetate in rats given stannous tin. J Nucl Med 1974;15:151-5
PUBMED
|
2 |
Greenberg DD, Som P, Meinken GE, Sacker DF, Atkins HL. Effects of preloading of stannous compounds on the distribution of Tc-99m pertechnetate. Nuklearmedizin 1977;16:26-9
PUBMED
|
3 |
Alderson PO, Bernier DR, Ludbrook PA, Harwig JF, Roberts R, Sobel BE. Serial radionuclide determinations of the ejection fraction with Tc-99m labeled red blood cells. Radiology 1976;119:729-30
DOI
PUBMED
|
4 |
Bunker SR, Brown JM, McAuley RJ, Lull RJ, Jackson JH, Hattner RS, et al. Detection of gastrointestinal bleeding sites. use of in vitro technetium Tc-99m labeled RBC's. JAMA 1982;247:789-92
|
5 |
Smith RK, Arterburn JG. The advantages of delayed imaging and radiographic correlation in scintigraphic localization of gastrointestinal bleeding. Radiology 1981;139:471-2
DOI
PUBMED
|
6 |
Yu KY, Cho SM, Shim SM, Cho KJ. The clinical comparison on cardiac blood pool scan agents labeling method. Kor J Nucl Med Tech 1986;2:39-41
|
7 |
Callahan RJ, Froelich JW, McKusick KA, Leppo J, Strauss HW. A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication. J Nucl Med 1982;23:315-8
PUBMED
|
8 |
Srivastava SC, Chervu LR. Radionuclide-labeled red blood cells:current status and future prospects. Semin Nucl Med 1984;14:68-82
DOI
ScienceOn
|
9 |
Kelly MJ, Cowie AR, Antonino A, Barton H, Kalff V. An assessment of factors which influence the effectiveness of the modified in vivo technetium-99m erythrocyte labeling technique in clinical use. J Nucl Med 1992;33:2222-5
PUBMED
|
10 |
Winzelberg GG, Froelich JW, McKusick KA, Waltman AC, Greenfield AJ, Athanasoulis CA, et al. Radionuclide localization of lower gastrointestinal hemorrhage. Radiology 1981;139:465-9
DOI
PUBMED
|
11 |
Porter WC, Dees SM, Freitas JE, Dworkin HJ. Acid-citrate-dextrose compared with heparin in the preparation of in vivo/in vitro technetium-99m red blood cells. J Nucl Med 1983;24:383-7
PUBMED
|
12 |
Wilson ME, Hung JC. Evaluation of heparin and anticoagualant citrate dextrose in the preparation of technetium-99m red blood cells with Ultra Tag RBC kit. J Nucl Med 1992;33:306-8
PUBMED
|
13 |
Thrall JH, Freitas JE, Swanson D, Rogers WL, Clare JM, Brown ML, et al. Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and with technetium-99m human serum albumin. J Nucl Med 1978;19:796-803
PUBMED
|
14 |
Armas RR, Thakur ML, Gottschalk A. A simplified method of selective spleen scintigraphy with Tc-99m labeled erythrocytes: clinical application. concise communication. J Nucl Med 1980;21:413-6
PUBMED
|
15 |
Chandler WM, Shuck LD. Effects of tin on pertechnetate distribution. J Nucl Med 1975;16:690
|
16 |
Front D, Israel O, Groshar D, Weininger J. Technetium-99m-labeled red blood imaging. Semin Nucl Med 1984;14:226-50
DOI
ScienceOn
|
17 |
Kulkarni PV, Parkey RW, Buja LM, Wilson JE 3rd, Bonte FJ, Willerson JT. Technetium-labeled heparin: preliminary report of a new radiopharmaceutical with potential for imaging damaged coronary arteries and myocardium. J Nucl Med 1978;19:810-5
PUBMED
|
18 |
Triplett DA. Heparin: biochemistry, therapy and laboratory monitoring. Ther Drug Monit 1979;1:173-97
DOI
PUBMED
ScienceOn
|
19 |
Callahan RJ, Rabito CA. Radiolabeling of erythrocytes with technetium-99m: role of band-3 protein in the transport of pertechnetate across the cell membrane. J Nucl Med 1990;31:2004-10
PUBMED
|
20 |
Callahan RJ, Ramberg KL. Radiolabeling formed elements of blood: methods and mechanisms. In: Henkin RE, Boles MA, Dillehay GL, Halama JR, Karesh SM, Wagner RH, editors. Nuclear Medicine. St. Louis: Mosby; 1996. p. 397-409
|
21 |
Front D, Israel O. Tc-99m labeled red blood cells in the evaluation of vascular abnormalities. J Nucl Med 1981;22:149-151
PUBMED
|